Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway

  • Authors:
    • Zhen Chen
    • Ninghua Ni
    • Yan Mei
    • Zhengrong Yang
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, The First People's Hospital of Yunnan, Kunming, Yunnan 650032, P.R. China, Research Center of Fundus Disease of Yunnan, The First People's Hospital of Yunnan, Kunming, Yunnan 650032, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4951-4957
    |
    Published online on: September 22, 2017
       https://doi.org/10.3892/etm.2017.5187
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Retinal pigment epithelial (RPE) cells have crucial roles in the initiation and development of human ophthalmic diseases. Our previous study suggested that transforming growth factor‑β (TGF‑β)‑activated kinase 1 (TAK1) is a potential target in the progression and pathogenesis of human proliferative vitreoretinopathy disease. The present study further analyzed the role of TAK1 inhibitor, LYTAK1, in human RPE cells and explored the potential molecular mechanism of LYTAK1‑mediated proliferation of human RPE cells. Proliferation of human RPE cells was investigated following treatment with LYTAK1 and knockdown of TGF‑β. TGF‑β‑mediated epithelial‑mesenchymal transition (EMT) through regulation of the extracellular signal‑regulated kinase (ERK)/protein kinase B (AKT) signaling pathway was also explored to analyze the LYTAK1‑mediated mechanism of proliferation in human RPE cells. The present results demonstrated that LYTAK1 administration suppressed TAK1 gene and protein expression in human RPE cells. LYTAK1 administration also inhibited proliferation and migration of human RPE cells in vitro. Outcomes indicated that LYTAK1 treatment downregulated expression levels of TGF‑β1 and EMT markers, including cadherin, fibronectin and α‑smooth muscle actin in human RPE cells. Notably, results demonstrated that the ERK/AKT signal pathway was blocked by LYTAK1 in human RPE cells. Knockdown of TGF‑β markedly inhibited phosphorylation and activity of TAK1 and suppressed the LYTAK1‑mediated ERK/AKT signaling pathway in RPE cells, which further canceled inhibition of RPE cell proliferation by LYTAK1. In conclusion, these findings indicated that LYTAK1 may inhibit RPE cell proliferation through the TGF‑β‑mediated EMT/ERK/AKT signaling pathway, suggesting that TAK1 may be a potential target for the treatment of RPE diseases.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Devarajan G, Niven J, Forrester JV and Crane IJ: Retinal pigment epithelial cell apoptosis is influenced by a combination of macrophages and soluble mediators present in age-related macular degeneration. Curr Eye Res. 41:1235–1244. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Chen M, Rajapakse D, Fraczek M, Luo C, Forrester JV and Xu H: Retinal pigment epithelial cell multinucleation in the aging eye-a mechanism to repair damage and maintain homoeostasis. Aging Cell. 15:436–445. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Joshi R, Mankowski W, Winter M, Saini JS, Blenkinsop TA, Stern JH, Temple S and Cohen AR: Automated measurement of cobblestone morphology for characterizing stem cell derived retinal pigment epithelial cell cultures. J Ocul Pharmacol Ther. 32:331–339. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Hanus J, Anderson C, Sarraf D, Ma J and Wang S: Retinal pigment epithelial cell necroptosis in response to sodium iodate. Cell Death Discov. 2:160542016. View Article : Google Scholar : PubMed/NCBI

5 

Lee GY, Kang SJ, Lee SJ, Song JE, Joo CK, Lee D and Khang G: Effects of small intestinal submucosa content on the adhesion and proliferation of retinal pigment epithelial cells on SIS-PLGA films. J Tissue Eng Regen Med. 11:99–108. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Brandstetter C, Patt J, Holz FG and Krohne TU: Inflammasome priming increases retinal pigment epithelial cell susceptibility to lipofuscin phototoxicity by changing the cell death mechanism from apoptosis to pyroptosis. J Photochem Photobiol B. 161:177–183. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Ying L, Chunxia Y and Wei L: Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1. Cancer Chemother Pharmacol. 76:641–650. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Sakurai H: Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci. 33:522–530. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Zhou J, Zheng B, Ji J, Shen F, Min H, Liu B, Wu J and Zhang S: LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo. Tumour Biol. 36:3301–3308. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Green YA, Ben-Yaakov K, Adir O, Pollack A and Dvashi Z: TAK1 is involved in the autophagy process in retinal pigment epithelial cells. Biochem Cell Biol. 94:188–196. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Dvashi Z, Green Y and Pollack A: TAK1 inhibition accelerates cellular senescence of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 55:5679–5686. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Chen Z, Mei Y, Lei H, Tian R, Ni N, Han F, Gan S and Sun S: LYTAK1, a TAK1 inhibitor, suppresses proliferation and epithelialmesenchymal transition in retinal pigment epithelium cells. Mol Med Rep. 14:145–150. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Chou WW, Chen KC, Wang YS, Wang JY, Liang CL and Juo SH: The role of SIRT1/AKT/ERK pathway in ultraviolet B induced damage on human retinal pigment epithelial cells. Toxicol In Vitro. 27:1728–1736. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Jiang Q, Cao C, Lu S, Kivlin R, Wallin B, Chu W, Bi Z, Wang X and Wan Y: MEK/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells. Int J Mol Med. 23:771–777. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Lee EJ, Park SJ, Kang SK, Kim GH, Kang HJ, Lee SW, Jeon HB and Kim HS: Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther. 20:1424–1433. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Chung EJ, Chun JN, Jung SA, Cho JW and Lee JH: TGF-β-stimulated aberrant expression of class III β-tubulin via the ERK signaling pathway in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun. 415:367–372. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Zhao P, Torcaso A, Mariano A, Xu L, Mohsin S, Zhao L and Han R: Anoctamin 6 regulates C2C12 myoblast proliferation. PLoS One. 9:e927492014. View Article : Google Scholar : PubMed/NCBI

18 

Chong CM and Zheng W: Artemisinin protects human retinal pigment epithelial cells from hydrogen peroxide-induced oxidative damage through activation of ERK/CREB signaling. Redox Biol. 9:50–56. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Stamp ME, Brugger MS, Wixforth A and Westerhausen C: Acoustotaxis -in vitro stimulation in a wound healing assay employing surface acoustic waves. Biomater Sci. 4:1092–1099. 2016. View Article : Google Scholar : PubMed/NCBI

21 

Kwon OW, Song JH and Roh MI: Retinal Detachment and Proliferative Vitreoretinopathy. Dev Ophthalmol. 55:154–162. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Lai FH, Lo EC, Chan VC, Brelen M, Lo WL and Young AL: Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy. Int Ophthalmol. 36:217–224. 2016. View Article : Google Scholar : PubMed/NCBI

23 

García S, López E and López-Colomé AM: Glutamate accelerates RPE cell proliferation through ERK1/2 activation via distinct receptor-specific mechanisms. J Cell Biochem. 104:377–390. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Palma-Nicolás JP, López E and López-Colomé AM: Thrombin stimulates RPE cell motility by PKC-zeta- and NF-kappaB-dependent gene expression of MCP-1 and CINC-1/GRO chemokines. J Cell Biochem. 110:948–967. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Sheridan CM, Magee RM, Hiscott PS, Hagan S, Wong DH, McGalliard JN and Grierson I: The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. Curr Eye Res. 25:279–285. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Winkler J and Hoerauf H: TGF-ß and RPE-derived cells in taut subretinal strands from patients with proliferative vitreoretinopathy. Eur J Ophthalmol. 21:422–426. 2011. View Article : Google Scholar : PubMed/NCBI

27 

He S, Barron E, Ishikawa K, Khanamiri H Nazari, Spee C, Zhou P, Kase S, Wang Z, Dustin LD and Hinton DR: Inhibition of DNA methylation and methyl-CpG-binding protein 2 suppresses RPE transdifferentiation: Relevance to proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 56:5579–5589. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Enzmann V, Hollborn M, Wiedemann P and Kohen L: Minor influence of the immunosuppressive cytokines IL-10 and TGF-beta on the proliferation and apoptosis of human retinal pigment epithelial (RPE) cells in vitro. Ocular Immunol Inflamm. 9:259–266. 2001. View Article : Google Scholar

29 

Alge-Priglinger CS, André S, Schoeffl H, Kampik A, Strauss RW, Kernt M, Gabius HJ and Priglinger SG: Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway. Biochimie. 93:477–488. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Qin D, Zheng XX and Jiang YR: Apelin-13 induces proliferation, migration, and collagen I mRNA expression in human RPE cells via PI3K/Akt and MEK/Erk signaling pathways. Mol Vis. 19:2227–2236. 2013.PubMed/NCBI

31 

Tang B, Cai J, Sun L, Li Y, Qu J, Snider BJ and Wu S: Proteasome inhibitors activate autophagy involving inhibition of PI3K-Akt-mTOR pathway as an anti-oxidation defense in human RPE cells. PLoS One. 9:e1033642014. View Article : Google Scholar : PubMed/NCBI

32 

Bulloj A, Duan W and Finnemann SC: PI 3-kinase independent role for AKT in F-actin regulation during outer segment phagocytosis by RPE cells. Exp Eye Res. 113:9–18. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Cheung YH, Sheridan CM, Lo AC and Lai WW: Lectin from Agaricus bisporus inhibited S phase cell population and Akt phosphorylation in human RPE cells. Invest Ophthalmol Vis Sci. 53:7469–7475. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen Z, Ni N, Mei Y and Yang Z: LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway. Exp Ther Med 14: 4951-4957, 2017.
APA
Chen, Z., Ni, N., Mei, Y., & Yang, Z. (2017). LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway. Experimental and Therapeutic Medicine, 14, 4951-4957. https://doi.org/10.3892/etm.2017.5187
MLA
Chen, Z., Ni, N., Mei, Y., Yang, Z."LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway". Experimental and Therapeutic Medicine 14.5 (2017): 4951-4957.
Chicago
Chen, Z., Ni, N., Mei, Y., Yang, Z."LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4951-4957. https://doi.org/10.3892/etm.2017.5187
Copy and paste a formatted citation
x
Spandidos Publications style
Chen Z, Ni N, Mei Y and Yang Z: LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway. Exp Ther Med 14: 4951-4957, 2017.
APA
Chen, Z., Ni, N., Mei, Y., & Yang, Z. (2017). LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway. Experimental and Therapeutic Medicine, 14, 4951-4957. https://doi.org/10.3892/etm.2017.5187
MLA
Chen, Z., Ni, N., Mei, Y., Yang, Z."LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway". Experimental and Therapeutic Medicine 14.5 (2017): 4951-4957.
Chicago
Chen, Z., Ni, N., Mei, Y., Yang, Z."LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF‑β‑mediated epithelial‑mesenchymal transition via the ERK/AKT signaling pathway". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4951-4957. https://doi.org/10.3892/etm.2017.5187
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team